Sheng-Zhi Liu1,2, Xue-Mei He3, Xu Zhang4, Fan-Cai Zeng5, Fang Wang6, Xiang-Yu Zhou7. 1. SouthWest Medical University Clinical Medicine, 25 Tai Ping Street, Lu Zhou, 646000, Sichuan Province, People's Republic of China. 2. Department of Vascular Surgery, The Second People's Hospital of Yibin, 96 North Street, Yi Bin, 644000, Sichuan Province, People's Republic of China. 3. Medical Research Center, The Affiliated Hospital of SouthWest Medical University, 25 Tai Ping Street, Lu Zhou, 646000, Sichuan Province, People's Republic of China. 4. Department of Pathology, The Affiliated Hospital of SouthWest Medical University, 25 Tai Ping Street, Lu Zhou, 646000, Sichuan Province, People's Republic of China. 5. Department of Biochemistry, SouthWest Medical University, 25 Tai Ping Street, Lu Zhou, 646000, Sichuan Province, People's Republic of China. 6. Department of Vascular and Thyroid Surgery, The Affiliated Hospital of SouthWest Medical University, 25 Tai Ping Street, Lu Zhou, 646000, Sichuan Province, People's Republic of China. 7. Department of Vascular and Thyroid Surgery, The Affiliated Hospital of SouthWest Medical University, 25 Tai Ping Street, Lu Zhou, 646000, Sichuan Province, People's Republic of China. xiangyuzhou971@126.com.
Abstract
BACKGROUND: The inflammatory immune response plays an important role in mesenteric ischemia and ischemia-reperfusion injury. Toll-like receptor 4 (TLR4) is a critical receptor in transduction of the inflammatory response and plays an important role in intestinal homeostasis. Tumor necrosis factor receptor-associated factor 6 (TRAF6), known as a key adaptor protein downstream of TLR4, is involved in the inflammatory response by activating multiple apoptotic signaling pathways. However, mechanisms of the suppressor of cytokine signaling-1 (SOCS-1) in regulating cell inflammation and apoptosis are still obscure. OBJECTIVES: To investigate the TLR4-TRAF6 signaling pathway in intestinal ischemia and reperfusion injury, as well as SOCS-1 expression after ischemic preconditioning in the rat intestine. METHODS: The small bowel ischemia, ischemia-reperfusion, and preconditioning models were induced using ligation of the superior mesenteric artery in male Sprague-Dawley rats; then, the mRNA and protein levels of TLR4, TRAF6, and SOCS-1 were analyzed using real-time PCR, Western blot, and immunohistochemistry, respectively. RESULTS: The expression of TLR4 and TRAF6 was gradually increased with increasing intestinal ischemia duration, but increased substantially after ischemia-reperfusion injury. After ischemic preconditioning, TLR4 and TRAF6 expressions decreased; however, expression of SOCS-1 and the TLR4-TRAF6 pathway inhibitor was increased. CONCLUSION: These data show that ischemic preconditioning may induce the activation of SOCS-1 to inhibit the TLR4-TRAF6 signaling pathway, thereby playing a protective role in ischemia-reperfusion injury.
BACKGROUND: The inflammatory immune response plays an important role in mesenteric ischemia and ischemia-reperfusion injury. Toll-like receptor 4 (TLR4) is a critical receptor in transduction of the inflammatory response and plays an important role in intestinal homeostasis. Tumor necrosis factor receptor-associated factor 6 (TRAF6), known as a key adaptor protein downstream of TLR4, is involved in the inflammatory response by activating multiple apoptotic signaling pathways. However, mechanisms of the suppressor of cytokine signaling-1 (SOCS-1) in regulating cell inflammation and apoptosis are still obscure. OBJECTIVES: To investigate the TLR4-TRAF6 signaling pathway in intestinal ischemia and reperfusion injury, as well as SOCS-1 expression after ischemic preconditioning in the rat intestine. METHODS: The small bowel ischemia, ischemia-reperfusion, and preconditioning models were induced using ligation of the superior mesenteric artery in male Sprague-Dawley rats; then, the mRNA and protein levels of TLR4, TRAF6, and SOCS-1 were analyzed using real-time PCR, Western blot, and immunohistochemistry, respectively. RESULTS: The expression of TLR4 and TRAF6 was gradually increased with increasing intestinal ischemia duration, but increased substantially after ischemia-reperfusion injury. After ischemic preconditioning, TLR4 and TRAF6 expressions decreased; however, expression of SOCS-1 and the TLR4-TRAF6 pathway inhibitor was increased. CONCLUSION: These data show that ischemic preconditioning may induce the activation of SOCS-1 to inhibit the TLR4-TRAF6 signaling pathway, thereby playing a protective role in ischemia-reperfusion injury.
Authors: Thiruma V Arumugam; Eitan Okun; Sung-Chun Tang; John Thundyil; Stephen M Taylor; Trent M Woodruff Journal: Shock Date: 2009-07 Impact factor: 3.454
Authors: Raimundo Fernandes de Araújo; Maria Patrícia Oliveira da Silva Reinaldo; Gerly Anne de Castro Brito; Pedro de França Cavalcanti; Marco Aurélio Freire; Marco Aurélio de Moura Freire; Caroline Addison Xavier de Medeiros; Aurigena Antunes de Araújo Journal: PLoS One Date: 2014-12-22 Impact factor: 3.240
Authors: Xin Fan; Juan Du; Mao-Hua Wang; Jia-Man Li; Bo Yang; Ye Chen; Jun-Chao Dai; Chunxiang Zhang; Jun Zhou Journal: Oxid Med Cell Longev Date: 2019-05-02 Impact factor: 6.543